Related Experiment Video

Updated: Jun 4, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Role of inflammation-related gene polymorphisms in patients with central retinal vein occlusion

Richard Maier1, Iris Steinbrugger, Anton Haas

  • 1Department of Ophthalmology, Medical University of Graz, Graz, Austria.

Ophthalmology
|January 29, 2011
PubMed

Insights

This study found no significant association between inflammation-related gene polymorphisms and central retinal vein occlusion (CRVO). Established risk factors like hypertension, diabetes, and smoking remain significant for CRVO development.

Area of Science:

  • Ophthalmology
  • Genetics
  • Internal Medicine

Background:

  • Central retinal vein occlusion (CRVO) is a significant cause of vision loss, particularly in individuals over 60.
  • Established risk factors include arterial hypertension and diabetes mellitus.
  • Inflammation-related gene polymorphisms are hypothesized as potential contributors to CRVO pathogenesis.

Purpose of the Study:

  • To investigate the association between inflammation-related gene polymorphisms and the risk of developing CRVO.
  • To determine if specific cytokine and chemokine gene polymorphisms are linked to CRVO in a large patient cohort.

Main Methods:

  • A case-control study was conducted with 315 CRVO patients and 335 controls.
  • Genotyping for polymorphisms in IL1β, IL1RN, IL4, IL6, IL10, IL18, TNF-α, MCP-1/CCL2, IL8, and RANTES was performed using a 5' exonuclease (TaqMan) assay.
  • Logistic regression analysis was used to assess the association between risk factors and CRVO.

Main Results:

  • No significant differences in genotype distributions or allele frequencies were observed for the investigated inflammation-related gene polymorphisms between CRVO patients and controls.
  • Arterial hypertension, diabetes mellitus, and cigarette smoking were significantly more prevalent in the CRVO group.
  • Arterial hypertension (OR 1.75), diabetes mellitus (OR 2.52), and smoking (OR 1.57) were identified as significant risk factors for CRVO.

Conclusions:

  • The investigated inflammation-related gene polymorphisms are unlikely to be major risk factors for central retinal vein occlusion.
  • Traditional risk factors such as hypertension, diabetes, and smoking play a significant role in the development of CRVO.
Abstract

More Related Videos

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography05:14

Characterization of Vascular Morphology of Neovascular Age-Related Macular Degeneration by Indocyanine Green Angiography

Published on: August 11, 2023

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...